Related Experiment Video
Updated: Aug 11, 2026

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Indications for and applications of the Gianturco-Roubin coronary stent
E T Fry1, J B Hermiller, T F Peters
1Nasser, Smith & Pinkerton Cardiology, Inc., Indiana Heart Institute, St. Vincent Hospital, Indianapolis.
Abstract:
The Gianturco-Roubin coronary stent is approved for and effective in the management of acute or threatened closure after unsuccessful coronary intervention. Factors critical to successful stenting include patient and lesion selection, preprocedure identification of patients in potential need of stenting, selection of stent-compatible ancillary equipment, appropriate antiplatelet and anticoagulant therapy, postdeployment stent dilatation, and careful sizing of stents. Further refinements of technique and adjunctive drug therapy should continue to improve results and avoid acute complications. Published clinical experience and potential future applications are discussed.

